The effectiveness of early treatment with "second-line" antirheumatic drugs. A randomized, controlled trial (Q53988786)
scientific article
Language:
Current Data About The effectiveness of early treatment with "second-line" antirheumatic drugs. A randomized, controlled trial
(P31) (Q13442814)
(P248)
(P698) 8633829
(P813) Wednesday, May 23, 2018
(P854) http://europepmc.org/abstract/MED/8633829

(P304) 699-707
(P248)
(P698) 8633829
(P813) Wednesday, May 23, 2018
(P854) http://europepmc.org/abstract/MED/8633829

(P407) (Q1860)

(P433) 8
(P248)
(P698) 8633829
(P813) Wednesday, May 23, 2018
(P854) http://europepmc.org/abstract/MED/8633829

(P478) 124
(P248)
(P698) 8633829
(P813) Wednesday, May 23, 2018
(P854) http://europepmc.org/abstract/MED/8633829

(P577) Monday, April 1, 1996
(P248)
(P698) 8633829
(P813) Wednesday, May 23, 2018
(P854) http://europepmc.org/abstract/MED/8633829

(P1433) (Q564416)
(P248)
(P698) 8633829
(P813) Wednesday, May 23, 2018
(P854) http://europepmc.org/abstract/MED/8633829

(P1476) "The effectiveness of early treatment with "second-line" antirheumatic drugs. A randomized, controlled trial" (language: en)
(P248)
(P698) 8633829
(P813) Wednesday, May 23, 2018
(P854) http://europepmc.org/abstract/MED/8633829

(P2093) van der Heide A
(P1545) 1
(P248)
(P698) 8633829
(P813) Wednesday, May 23, 2018
(P854) http://europepmc.org/abstract/MED/8633829

Jacobs JW
(P1545) 2
(P248)
(P698) 8633829
(P813) Wednesday, May 23, 2018
(P854) http://europepmc.org/abstract/MED/8633829

Bijlsma JW
(P1545) 3
(P248)
(P698) 8633829
(P813) Wednesday, May 23, 2018
(P854) http://europepmc.org/abstract/MED/8633829

Heurkens AH
(P1545) 4
(P248)
(P698) 8633829
(P813) Wednesday, May 23, 2018
(P854) http://europepmc.org/abstract/MED/8633829

van Booma-Frankfort C
(P1545) 5
(P248)
(P698) 8633829
(P813) Wednesday, May 23, 2018
(P854) http://europepmc.org/abstract/MED/8633829

van der Veen MJ
(P1545) 6
(P248)
(P698) 8633829
(P813) Wednesday, May 23, 2018
(P854) http://europepmc.org/abstract/MED/8633829

Haanen HC
(P1545) 7
(P248)
(P698) 8633829
(P813) Wednesday, May 23, 2018
(P854) http://europepmc.org/abstract/MED/8633829

Hofman DM
(P1545) 8
(P248)
(P698) 8633829
(P813) Wednesday, May 23, 2018
(P854) http://europepmc.org/abstract/MED/8633829

van Albada-Kuipers GA
(P1545) 9
(P248)
(P698) 8633829
(P813) Wednesday, May 23, 2018
(P854) http://europepmc.org/abstract/MED/8633829

ter Borg EJ
(P1545) 10
(P248)
(P698) 8633829
(P813) Wednesday, May 23, 2018
(P854) http://europepmc.org/abstract/MED/8633829

Brus HL
(P1545) 11
(P248)
(P698) 8633829
(P813) Wednesday, May 23, 2018
(P854) http://europepmc.org/abstract/MED/8633829

Dinant HJ
(P1545) 12
(P248)
(P698) 8633829
(P813) Wednesday, May 23, 2018
(P854) http://europepmc.org/abstract/MED/8633829

Kruize AA
(P1545) 13
(P248)
(P698) 8633829
(P813) Wednesday, May 23, 2018
(P854) http://europepmc.org/abstract/MED/8633829

Schenk Y
(P1545) 14
(P248)
(P698) 8633829
(P813) Wednesday, May 23, 2018
(P854) http://europepmc.org/abstract/MED/8633829

other details
description scientific article

External Links
(P356) 10.7326/0003-4819-124-8-199604150-00001
(P698) 8633829